Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Injectable colloidal gold for use in intrafractional 2D image-guided radiation therapy

Jølck, Rasmus I. ; Rydhög, Jonas S. ; Christensen, Anders N. ; Hansen, Anders E. ; Bruun, Linda M. ; Schaarup-Jensen, Henrik ; von Wenck, Asger Stevner ; Børresen, Betina ; Kristensen, Annemarie T. and Clausen, Mads H. , et al. (2015) In Advanced healthcare materials 4(6). p.856-863
Abstract

In the western world, approximately 50% of all cancer patients receive radiotherapy alone or in combination with surgery or chemotherapy. Image-guided radiotherapy (IGRT) has in recent years been introduced to enhance precision of the delivery of radiation dose to tumor tissue. Fiducial markers are often inserted inside the tumor to improve IGRT precision and to enable monitoring of the tumor position during radiation therapy. In the present article, a liquid fiducial tissue marker is presented, which can be injected into tumor tissue using thin and flexible needles. The liquid fiducial has high radio-opacity, which allows for marker-based image guidance in 2D and 3D X-ray imaging during radiation therapy. This is achieved by... (More)

In the western world, approximately 50% of all cancer patients receive radiotherapy alone or in combination with surgery or chemotherapy. Image-guided radiotherapy (IGRT) has in recent years been introduced to enhance precision of the delivery of radiation dose to tumor tissue. Fiducial markers are often inserted inside the tumor to improve IGRT precision and to enable monitoring of the tumor position during radiation therapy. In the present article, a liquid fiducial tissue marker is presented, which can be injected into tumor tissue using thin and flexible needles. The liquid fiducial has high radio-opacity, which allows for marker-based image guidance in 2D and 3D X-ray imaging during radiation therapy. This is achieved by surface-engineering gold nanoparticles to be highly compatible with a carbohydrate-based gelation matrix. The new fiducial marker is investigated in mice where they are highly biocompatible and stable after implantation. To investigate the clinical potential, a study is conducted in a canine cancer patient with spontaneous developed solid tumor in which the marker is successfully injected and used to align and image-guide radiation treatment of the canine patient. It is concluded that the new fiducial marker has highly interesting properties that warrant investigations in cancer patients. First liquid fiducial marker for image-guided radiation therapy is visible in both 2D- and 3D X-ray-based imaging. Doping sucrose acetate isobutyrate with poly(N-isopropyl acrylamide)-coated gold nanoparticles results in a liquid fiducial marker (nanogel) with a contrast level >1000 HU. External radiation therapy is delivered by depositing the nanogel intratumorally in a canine patient with spontaneous cancer, providing evidence of the clinical potential of the developed nanogel.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Computed tomography, Fiducial markers, Gold nanoparticles, Image-guided radiation therapy, Sucrose acetate isobutyrate
in
Advanced healthcare materials
volume
4
issue
6
pages
856 - 863
publisher
John Wiley & Sons Inc.
external identifiers
  • pmid:25607532
  • scopus:84928212391
ISSN
2192-2640
DOI
10.1002/adhm.201400651
language
English
LU publication?
no
additional info
Publisher Copyright: © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
id
1cc57eb8-b3b8-4d4b-964c-b398efa6796e
date added to LUP
2023-07-19 17:15:25
date last changed
2024-03-08 03:47:08
@article{1cc57eb8-b3b8-4d4b-964c-b398efa6796e,
  abstract     = {{<p>In the western world, approximately 50% of all cancer patients receive radiotherapy alone or in combination with surgery or chemotherapy. Image-guided radiotherapy (IGRT) has in recent years been introduced to enhance precision of the delivery of radiation dose to tumor tissue. Fiducial markers are often inserted inside the tumor to improve IGRT precision and to enable monitoring of the tumor position during radiation therapy. In the present article, a liquid fiducial tissue marker is presented, which can be injected into tumor tissue using thin and flexible needles. The liquid fiducial has high radio-opacity, which allows for marker-based image guidance in 2D and 3D X-ray imaging during radiation therapy. This is achieved by surface-engineering gold nanoparticles to be highly compatible with a carbohydrate-based gelation matrix. The new fiducial marker is investigated in mice where they are highly biocompatible and stable after implantation. To investigate the clinical potential, a study is conducted in a canine cancer patient with spontaneous developed solid tumor in which the marker is successfully injected and used to align and image-guide radiation treatment of the canine patient. It is concluded that the new fiducial marker has highly interesting properties that warrant investigations in cancer patients. First liquid fiducial marker for image-guided radiation therapy is visible in both 2D- and 3D X-ray-based imaging. Doping sucrose acetate isobutyrate with poly(N-isopropyl acrylamide)-coated gold nanoparticles results in a liquid fiducial marker (nanogel) with a contrast level &gt;1000 HU. External radiation therapy is delivered by depositing the nanogel intratumorally in a canine patient with spontaneous cancer, providing evidence of the clinical potential of the developed nanogel.</p>}},
  author       = {{Jølck, Rasmus I. and Rydhög, Jonas S. and Christensen, Anders N. and Hansen, Anders E. and Bruun, Linda M. and Schaarup-Jensen, Henrik and von Wenck, Asger Stevner and Børresen, Betina and Kristensen, Annemarie T. and Clausen, Mads H. and Kjær, Andreas and Conradsen, Knut and Larsen, Rasmus and af Rosenschöld, Per Munck and Andresen, Thomas L.}},
  issn         = {{2192-2640}},
  keywords     = {{Computed tomography; Fiducial markers; Gold nanoparticles; Image-guided radiation therapy; Sucrose acetate isobutyrate}},
  language     = {{eng}},
  month        = {{04}},
  number       = {{6}},
  pages        = {{856--863}},
  publisher    = {{John Wiley & Sons Inc.}},
  series       = {{Advanced healthcare materials}},
  title        = {{Injectable colloidal gold for use in intrafractional 2D image-guided radiation therapy}},
  url          = {{http://dx.doi.org/10.1002/adhm.201400651}},
  doi          = {{10.1002/adhm.201400651}},
  volume       = {{4}},
  year         = {{2015}},
}